Empowering clinicians and patients in antipsychotic dose reduction for schizophrenia: the role of online tools

Stefan Leucht, Alessandro Rodolico · 2025

Read Empowering clinicians and patients in antipsychotic dose reduction for schizophrenia: the role of online tools by Stefan Leucht, Alessandro Rodolico (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12712091.txt.

Description

Stefan Leucht and Alessandro Rodolico weigh the debate on lowering or stopping antipsychotic drugs in schizophrenia, and point readers to online tools that support shared decisions. Stopping carries high relapse risk, they note: drugs cut one year relapse from about 65 to about 27 in 100. Their 2025 piece summarizes the evidence on both sides.

Dose cuts below a standard level raise relapse risk in a steep way, and stop and restart plans fare worse than steady treatment. Side effects do grow with dose, but switching drugs is usually safer than deep cuts, they argue. The authors also review claims about brain volume change. Their close urges empowering patients and clinicians with solid information centers.

Catalog record

CREATORStefan Leucht, Alessandro Rodolico
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE12 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12712091

Browse the full library · About the Tower of Babel